Vor Biopharma Inc (VOR)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
May 03, 16:00
1.795
0.00 (0.00%)
Pre-Market: 20:00
Vor Biopharma Total Liabilities (Quarterly): 47.40M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.40M |
| September 30, 2023 | 48.24M |
| June 30, 2023 | 46.54M |
| March 31, 2023 | 47.32M |
| December 31, 2022 | 48.76M |
| September 30, 2022 | 47.64M |
| June 30, 2022 | 49.64M |
| March 31, 2022 | 39.82M |
| Date | Value |
|---|---|
| December 31, 2021 | 26.33M |
| September 30, 2021 | 25.68M |
| June 30, 2021 | 25.04M |
| March 31, 2021 | 25.75M |
| December 31, 2020 | 27.64M |
| September 30, 2020 | 25.33M |
| December 31, 2019 | 2.186M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.186M
Minimum
Dec 2019
49.64M
Maximum
Jun 2022
35.55M
Average
39.82M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Masimo Corp | 1.677B |
| AnaptysBio Inc | 364.29M |
| Apellis Pharmaceuticals Inc | 594.21M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 198.13M |
| Shareholders Equity (Quarterly) | 150.72M |